Minor
COMPASS 2-HS · BFB759 in Moderate to Severe Hidradenitis Suppurativa
Enrollment closed, study ongoing
Bluefin Biomedicine, Inc.Phase 2/3 NCT07287644 Registry history of NCT07287644 on ClinicalTrials.gov (opens the registry)
Updated
2 active trials 0 recruiting 1 Phase 3 2 disease areas 1 changes in 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Enrollment closed, study ongoing
Bluefin Biomedicine, Inc.Phase 2/3 NCT07287644 Registry history of NCT07287644 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 2 | 1 | |
| Phase 2/3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2/3 | ||||
| NCT07287644 | A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa | Hidradenitis Suppurativa (HS) | Active, Not Recruiting | 2026-10-01 |
| Phase 2 | ||||
| NCT07105488 | A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis | Atopic Dermatitis (AD) | Active, Not Recruiting | 2026-07-30 |
Atopic Dermatitis (1) · Hidradenitis Suppurativa (1)